Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125788071 | 12578807 | 1 | I | 2014 | 20160715 | 20160721 | 20160721 | EXP | AU-EISAI MEDICAL RESEARCH-EC-2016-018744 | EISAI | 0.00 | M | Y | 0.00000 | 20160721 | CN | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125788071 | 12578807 | 1 | PS | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | UNKNOWN | Y | 20973 | TABLET | ||||||||
125788071 | 12578807 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | UNKNOWN | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125788071 | 12578807 | 1 | Product used for unknown indication |
125788071 | 12578807 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125788071 | 12578807 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125788071 | 12578807 | Chest pain | |
125788071 | 12578807 | Cough | |
125788071 | 12578807 | Insomnia | |
125788071 | 12578807 | Muscular weakness | |
125788071 | 12578807 | Oropharyngeal pain | |
125788071 | 12578807 | Palpitations | |
125788071 | 12578807 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125788071 | 12578807 | 1 | 201411 | 20160711 | 0 |